PHIO PHARMACEUTICALS CORP. Interest Expense Nonoperating
PHIO PHARMACEUTICALS CORP. (PHIO) reported Interest Expense Nonoperating of -$125.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2025-05-15
- PHIO PHARMACEUTICALS CORP. interest expense nonoperating for the quarter ending 2025-03-31 was -$125.00K.
- PHIO PHARMACEUTICALS CORP. interest expense nonoperating for the quarter ending 2024-03-31 was -$53.00K.
| Period end | Interest Expense Nonoperating 3 month |
|---|---|
| 2025-03-31 | -$125.00K 10-Q · filed 2025-05-15 |
| 2024-03-31 | -$53.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |